CORNERSTONE GOVERNMENT AFFAIRS, INC.

Lobbying for OCTAPHARMA USA, INC. · Pharmaceuticals

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · Senate · $90,000.00 income · posted Jan 12, 2026

Lobbying activity 3

Trade (domestic/foreign)

Educated government stakeholders on Octapharmas product and manufacturing capabilities in support of National Security.

Medical/Disease Research/Clinical Labs

Educated government stakeholders on Octapharmas product and manufacturing capabilities in support of National Security.

Manufacturing

Educated government stakeholders on Octapharmas product and manufacturing capabilities in support of National Security.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.